Literature DB >> 31184313

Lisinopril reverses behavioural alterations in spontaneously hypertensive rats.

Kristina Repova1, Silvia Aziriova, Dominika Kovacova, Simona Trubacova, Tomas Baka, Romana Kanska, Andrej Barta, Peter Stanko, Stefan Zorad, Lubos Molcan, Michaela Adamcova, Ludovit Paulis, Fedor Simko.   

Abstract

This study investigated the effect of lisinopril (angiotensin-converting enzyme inhibitor) on potential behavioural alterations in spontaneously hypertensive rats (SHR). Three groups of 15-17-week-old rats were investigated for 2 weeks: Wistar control group, SHR group and SHR+lisinopril group. Systolic blood pressure (SBP) was normal in Wistar rats, SHR expressed hypertension and lisinopril normalized the SBP. We observed increased time spent in and increased frequency of entries to the central area of the open field in SHR, while lisinopril induced a trend to reduce the time spent in the central area of the open field and reduced the frequency of entries there. There was a positive correlation between SBP and reduced anxiety-like behaviour in normotensive rats; no correlations in the SHR or SHR+lisinopril groups were observed. We conclude that lisinopril normalized the increase in SBP and partly reversed the alterations of anxiety-like behaviour in SHR.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31184313     DOI: 10.4149/gpb_2019011

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  2 in total

1.  Effects of Aqueous Extract of Lycopersicum esculentum L. var. "Camone" Tomato on Blood Pressure, Behavior and Brain Susceptibility to Oxidative Stress in Spontaneously Hypertensive Rats.

Authors:  Maria Frosini; Paola Marcolongo; Alessandra Gamberucci; Gabriella Tamasi; Alessio Pardini; Roberta Giunti; Paolo Fiorenzani; Anna Maria Aloisi; Claudio Rossi; Federica Pessina
Journal:  Pathophysiology       Date:  2021-03-18

Review 2.  Cardiovascular therapeutics: A new potential for anxiety treatment?

Authors:  Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Fedor Simko
Journal:  Med Res Rev       Date:  2022-01-06       Impact factor: 12.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.